BIOCON Q2 Results: Revenue rose by 3.00% year-over-year (YoY) to Rs. 3590 crore, while net profit declined by 85.00% YoY to Rs. 27 crore.
Biocon is engaged in the business of manufacture of biotechnology products and research services.
Revenue
Revenue for the current quarter (Sep 2024) is Rs. 3590 crore which is Rs. 3433 crore more than the revenue in the previous quarter (Jun 2024). However, it is higher than the revenue for the same quarter last year (Sep 2023) which was Rs. 3462 crore.
Net Profit
Net Profit for the current quarter (Sep 2024) is Rs. 27 crore, which is Rs. 862 crore less than the net profit in the previous quarter (Jun 2024). However, compared to the same quarter last year, it is significantly lower than the net profit of Rs. 173 crore for Sep 2023.
Other Income
Other income for the current quarter (Sep 2024) is Rs. 58 crore, which is Rs. 1166 crore less than the other income for the previous quarter (Jun 2024). However, compared to the same quarter last year, it is lower than the other income of Rs. 134 crore for Sep 2023.